Why Sydney?
The ethnic diversity of Sydney's population, coupled with the large available pool of pharmaceutical and research skills, position Sydney as an optimal location for clinical trials.
Sydney's research institutes are top performers in meeting recruitment timelines and targets. Over 80% of clinical trials are completed on time.
Investigator fees per patient are half those of the US and Canada. Australia's relative cost advantage holds up in all phases and therapeutic areas. Australia's costs for conducting clinical trials are comparable to those in Eastern Europe, with medical practise and research standards similar to that in the US and Western Europe.
Sydney - First for Clinical Trials
The NSW Clinical Trials Business Development Centre, an initiative of the NSW Government, is the first point of contact for sponsors wishing to find out more about what Sydney, Australia, can offer for clinical development.
We have access to outstanding infrastructure for conducting clinical trials and provide clinical trial strategies tailored for product research and development for pharmaceutical, biotechnology and medical device companies. We can also assist you to access the following information and services: study design and management, data management and analysis, and regulatory affairs services.
With its prime location in the Asia Pacific region and its proximity to other Asia Pacific countries and time zones, Australia's competitive advantages include:
- well-developed infrastructure for conducting clinical trials, affiliated with major teaching hospitals
- an international standard regulatory system
- experienced and well-trained clinical trial investigators and related staff
- low cost, high quality clinical trials
- strong intellectual property laws
For cost, quality, and speed, Sydney is the first choice for companies seeking competitive advantages when choosing clinical development partners.
For more information, email info@clinicaltrials.org.au or call +61 2 8374 3569